chr20-58389472-G-A
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The NM_004738.5(VAPB):c.13G>A(p.Glu5Lys) variant causes a missense change. The variant allele was found at a frequency of 0.0000104 in 1,444,960 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. E5G) has been classified as Uncertain significance.
Frequency
Consequence
NM_004738.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -6 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
VAPB | NM_004738.5 | c.13G>A | p.Glu5Lys | missense_variant | 1/6 | ENST00000475243.6 | |
VAPB | NM_001195677.2 | c.13G>A | p.Glu5Lys | missense_variant | 1/3 | ||
VAPB | NR_036633.2 | n.244G>A | non_coding_transcript_exon_variant | 1/4 | |||
VAPB | XR_001754433.3 | n.244G>A | non_coding_transcript_exon_variant | 1/6 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
VAPB | ENST00000475243.6 | c.13G>A | p.Glu5Lys | missense_variant | 1/6 | 1 | NM_004738.5 | P1 | |
VAPB | ENST00000395802.7 | c.13G>A | p.Glu5Lys | missense_variant | 1/3 | 1 | |||
VAPB | ENST00000265619.6 | n.98G>A | non_coding_transcript_exon_variant | 1/6 | 2 | ||||
VAPB | ENST00000520497.1 | c.13G>A | p.Glu5Lys | missense_variant, NMD_transcript_variant | 1/4 | 2 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 exomes AF: 0.00000448 AC: 1AN: 223218Hom.: 0 AF XY: 0.00000824 AC XY: 1AN XY: 121392
GnomAD4 exome AF: 0.0000104 AC: 15AN: 1444960Hom.: 0 Cov.: 32 AF XY: 0.00000836 AC XY: 6AN XY: 717520
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Amyotrophic lateral sclerosis type 8;C1854058:Adult-onset proximal spinal muscular atrophy, autosomal dominant Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Mar 13, 2022 | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may create or strengthen a splice site. Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Not Available"; PolyPhen-2: "Benign"; Align-GVGD: "Not Available"). This variant has not been reported in the literature in individuals affected with VAPB-related conditions. The frequency data for this variant in the population databases is considered unreliable, as metrics indicate poor data quality at this position in the gnomAD database. This sequence change replaces glutamic acid, which is acidic and polar, with lysine, which is basic and polar, at codon 5 of the VAPB protein (p.Glu5Lys). - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at